Shopping Cart
- Remove All
- Your shopping cart is currently empty
GDC-0927 is a novel,non-steroidal, potent, orally bioavailable, selective estrogen receptor antagonist.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $747 | 7-10 days | |
25 mg | $1,610 | 7-10 days | |
50 mg | $2,570 | 7-10 days |
Description | GDC-0927 is a novel,non-steroidal, potent, orally bioavailable, selective estrogen receptor antagonist. |
In vivo | GDC-0927, a novel and potent non-steroidal, orally bioavailable selective estrogen receptor (ER) antagonist/degrader (SERD), effectively induces tumor regression in patient-derived xenograft models of estrogen receptor-positive (ER+) breast cancer (BC). |
Alias | SRN-927 |
Molecular Weight | 461.52 |
Formula | C28H28FNO4 |
Cas No. | 1642297-01-5 |
Relative Density. | 1.257 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 83.33 mg/mL (180.56 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.